Toxicity profile of antibody-drug conjugates in breast cancer: practical considerationsA. D'Arienzo, Filippo Montemurro, Mario Giuliano et al.|EClinicalMedicine|2023Cited by 90
Prevalence of Sarcopenia in Women with Breast CancerD. Morlino, Fabrizio Pasanisi, Maurizio Marra et al.|Nutrients|2022Cited by 31
Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor–Positive, <i>ERBB2</i>–Negative Metastatic Breast CancerPier Paolo Maria Berton Giachetti, Carmen Criscitiello, Stefania Morganti et al.|JAMA Network Open|2025Cited by 11
Gender minorities in breast cancer – Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patientsFederica Miglietta, Grazia Arpino, Letizia Pontolillo et al.|The Breast|2024Cited by 9